F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes - Top-Institutions - MDSpire

F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes

  • By

  • Bowen Wang

  • Ruban Dhaliwal

  • Susan K Ewing

  • Ann V Schwartz

  • Deepak Vashishth

  • November 8, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Diabetes Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Bone Biology
    • Diabetes Complications

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Diabetes Research

  • #4

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Diabetes

Original Source(s)

F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes

  • by Bowen Wang, Ruban Dhaliwal, Susan K Ewing, Ann V Schwartz, Deepak Vashishth

  • November 8, 2024

Related Content

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

AI Screening for Diabetic Retinopathy

AI system shows high accuracy for diabetic retinopathy screening

"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."